GeoVax Labs, Inc.
GeoVax Labs develops MVA-based vaccines for mpox and smallpox, with GEO-MVA entering Phase 3 in late 2026.
S-1Sep 17Latest SEC filing
Sep 17Latest story
Sign inSign inGeoVax Labs develops MVA-based vaccines for mpox and smallpox, with GEO-MVA entering Phase 3 in late 2026.